AskTheDate.com
Back to calendar

Arbutus Biopharma Corporation (ABUS) Earnings

ABUS reports earnings on Wednesday, November 11, 2026

earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.02
Actual EPS: $-0.03
EPS surprise: -50.00%
Company overview
Market Cap$1.0B
PriceUSD 5.09
P/E6.50
EPS (TTM)0.78
52-week high5.45
52-week low3.50
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees19
Buy me a coffee